Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Rory Riggs
AddedMar 31, 2024
UpdatedJun 28, 2026
Rory Riggs

Rory Riggs

Board Member, Royalty Pharma

Crunchbase

Rory Riggs's Career

Royalty Pharma
Royalty Pharma

New York City, NY, US

Board Member· Board
Intra-Cellular Therapies
Intra-Cellular Therapies

New York City, NY, US

Board Member· Board
Kyntra Bio
Kyntra Bio

San Francisco, CA, US

Board Member· Board
Ereceivables
Ereceivables

Coral Springs, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Rory Riggs's Career

Royalty Pharma
Royalty Pharma
Public751996New York City, NY, US
Board Member· Board

Leadership at Royalty Pharma

Cathy EngelbertCathy EngelbertBoard Member
Pablo G LegorretaPablo G LegorretaBoard Member
Henry FernandezHenry FernandezBoard Member
David HodgsonDavid HodgsonBoard Member
Ted LoveTed LoveBoard Member
Christopher HiteChristopher HiteBoard Member

Similar to Royalty Pharma

Roivant SciencesRoivant SciencesNew York City, NY, USDrug Developmentest. 2014Roivant SciencesNew York City, NY, US · est. 2014

NY-based Roivant Sciences is a biopharmaceutical firm dedicated to advancing promising drugs for patient care.

Public · $2.5B267
XOMA RoyaltyXOMA RoyaltyEmeryville, CA, USRoyalty Acquisitionest. 1981XOMA RoyaltyEmeryville, CA, US · est. 1981

XOMA Corporation, a biotech royalty aggregator, acquires economic rights to clinical candidates, aiding health improvement.

Public · $295.8M96
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
PharmosPharmosIselin, NJ, USDrug Developmentest. 1982PharmosIselin, NJ, US · est. 1982

W World Corp.: A bio-pharmaceutical firm innovating new drugs for neuroinflammatory disorders.

Public · $9.5M2
Intra-Cellular Therapies
Intra-Cellular Therapies
Public$691.7M5612002New York City, NY, US
Board Member· Board

Leadership at Intra-Cellular Therapies

Sharon MatesSharon MatesBoard Member
Allen A FienbergAllen A FienbergCo-Founder
Robert L Van NostrandRobert L Van NostrandBoard Member
Kyntra Bio
Kyntra Bio
Public$188M5921993San Francisco, CA, US
Board Member· Board

Leadership at Kyntra Bio

Jim SchoeneckJim SchoeneckBoard Member
Thane WettigThane WettigBoard Member
Jeffrey L EdwardsJeffrey L EdwardsBoard Member
Thomas NeffThomas NeffCo-Founder
Dr. Barry A. Berkowitz Ph.D.Dr. Barry A. Berkowitz Ph.D.Co-Founder
Dr May-kin HoDr May-kin HoBoard Member

Similar to Kyntra Bio

MacroGenicsMacroGenicsRockville, MD, USest. 2000MacroGenicsRockville, MD, US · est. 2000

US-based MacroGenics, Inc. develops novel biologics for cancer, autoimmune disorders, and infectious diseases.

Public · $165.9M357
BridgeBio PharmaBridgeBio PharmaPalo Alto, CA, USGenetic Medicinesest. 2015BridgeBio PharmaPalo Alto, CA, US · est. 2015

Bridgebio Pharma, a US-based biotech firm, specializes in developing medicines for genetic diseases globally.

Public · $3.6B392
GenentechGenentechSouth San Francisco, CA, USBiopharmaceuticalsest. 1976GenentechSouth San Francisco, CA, US · est. 1976

Genentech, Inc.: A pioneering US biotech firm, operating as an independent subsidiary of Roche.

Public13.5k
Pliant TherapeuticsPliant TherapeuticsSouth San Francisco, CA, USTherapeuticsest. 2015Pliant TherapeuticsSouth San Francisco, CA, US · est. 2015

Pliant Therapeutics: A California-based biopharmaceutical company innovating therapies for fibrotic diseases.

Public · $694.9M124
Ereceivables
Ereceivables
Investment FirmInvestment Firm$2.8M562003Coral Springs, FL, US
Board Member· Board

Leadership at Ereceivables

STEVEN \"GRIFF\" GRIFFINSTEVEN \"GRIFF\" GRIFFINBoard Member

Similar to Ereceivables

HbcsHbcsNew Castle, DE, USest. 1984HbcsNew Castle, DE, US · est. 1984

US-based healthcare management firm specializing in accounts receivable services and insurance maximization since 1984.

Investment Firm · $18.3M750
DaisyBillDaisyBillClaymont, DE, USest. 2012DaisyBillClaymont, DE, US · est. 2012

DaisyBill: Streamlining workers' compensation with innovative eBilling software solutions.

Investment Firm · $20k17
eHealthClaimeHealthClaimHuntsville, AL, USest. 1999eHealthClaimHuntsville, AL, US · est. 1999

eHealthClaim simplifies healthcare finances with online tools to track, understand, and organize medical bills and insurance claims.

Investment Firm · $1.7M5
ClaimForceClaimForceDeerfield, IL, USest. 2002ClaimForceDeerfield, IL, US · est. 2002

Claimforce, Inc.: Streamlining insurance claims processing with comprehensive software solutions.

Investment Firm · $650.1k30

Rory Riggs's Co-Investors

Nathaniel RuNathaniel RuCo-invested · Bond Street Series ALarry GrafsteinLarry GrafsteinCo-invested · Bond Street Series AJonathan NemanJonathan NemanCo-invested · Bond Street Series ANathan BlecharczykNathan BlecharczykCo-invested · Bond Street Series ANicolas JammetNicolas JammetCo-invested · Bond Street Series ADavid ChangDavid ChangCo-invested · Bond Street Series ANathan BlecharczykNathan BlecharczykCo-invested · Bond Street Series AH.P. GoldfieldH.P. GoldfieldCo-invested · Bond Street Series A

Rory Riggs's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Rory Riggs

Kirk MalloyKirk MalloyBoard Member · NanoString TechnologiesDavid S. KabakoffDavid S. KabakoffBoard Member · NextCureToby RedshawToby RedshawBoard Member · DocusignColin HallColin HallBoard Member · GlobalityRyan AllisRyan AllisBoard Member · TatangoJulia P. GregoryJulia P. GregoryBoard Member · Nurix